LWIC
XENE icon

Leith Wheeler Investment Counsel’s Xenon Pharmaceuticals XENE Stock Holding History

Leith Wheeler Investment Counsel’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-16,075
Closed -$147K – 34
2018
Q2 		$147K Hold
16,075
– – 0.05% 30
2018
Q1 		$79K Hold
16,075
– – 0.08% 30
2017
Q4 		$45K Hold
16,075
– – 0.08% 33
2017
Q3 		$47K Hold
16,075
– – 0.02% 31
2017
Q2 		$51K Hold
16,075
– – 0.02% 31
2017
Q1 		$64K Buy
+16,075
New +$126K 0.04% 33
2016
Q4 		– Sell
-16,075
Closed -$171K – 24
2016
Q3 		$171K Sell
16,075
-1,794
-10% -$13.9K 0.11% 12
2016
Q2 		$370K Buy
17,869
+1,794
+11% +$12.3K 0.25% 6
2016
Q1 		$146K Hold
16,075
– – 0.11% 12
2015
Q4 		$178K Buy
+16,075
New +$138K 0.14% 10

Other funds holding XENE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Leith Wheeler Investment Counsel's XENE Position: Q3 2018 in Review

Leith Wheeler Investment Counsel sold out of Xenon Pharmaceuticals (XENE) in Q3 2018, closing a stake of 16,075 shares — an estimated $147K sold.

Leith Wheeler Investment Counsel first reported a position in XENE in Q4 2015 and held it in 10 quarters. The position peaked at $370K in Q2 2016. 59 funds tracked by Wall St. Rank hold XENE as of Q3 2018.

  • Leith Wheeler Investment Counsel reported no remaining Xenon Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Leith Wheeler Investment Counsel sold 16,075 Xenon Pharmaceuticals shares in Q3 2018, an estimated $147K.
  • Leith Wheeler Investment Counsel first reported a position in Xenon Pharmaceuticals in Q4 2015 and held it in 10 quarters.
  • Leith Wheeler Investment Counsel's Xenon Pharmaceuticals position peaked at $370K in Q2 2016.
  • 59 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2018.

Based on Leith Wheeler Investment Counsel's 13F filing for Q3 2018, filed 22 Oct 2018.